Reproducible and Efficient Phenotyping for Cell Therapy Manufacturing Using the Accellix Automated Flow Cytometer...

Area of Science:

• Cellular therapy
• Biotechnology
• Analytical chemistry

Background:

• Cellular quality attributes are vital for ensuring the safety, efficacy, and consistency of cell therapies.
• Current methods, like flow cytometry, face standardization challenges impacting regulatory compliance (Good Manufacturing Practice).
• Critical Quality Attributes (CQAs) are essential for process monitoring and validating therapeutic effectiveness.

Purpose of the Study:

• To evaluate the Accellix Platform for automated cellular sample analysis.
• To assess the repeatability and reproducibility of the Accellix Platform across different sites, operators, and instruments.

Main Methods:

• The Accellix Platform was used for automated cellular sample analysis.
• Repeatability and reproducibility were assessed across multiple sites, operators, and dedicated instruments.

Main Results:

• The Accellix Platform demonstrated feasibility for automated cellular sample analysis.
• Data confirmed high repeatability and reproducibility of the platform across various testing conditions.

Conclusions:

• The Accellix Platform shows potential for robust and compliant manufacturing of innovative cellular therapies.
• Combining cytometry automation with advanced T cell engineering can enhance cell therapy production.